MAPT and Alzheimer disease: Interestingly, nuclear Tau has also been involved in nucleolar transcription (Maina et al., 2018) and the decrease in nuclear Tau (detected with Tau-100 antibody) that takes place in AD CA1 and dentate gyrus neurons along disease progression might be pathogenic by leading to decreased protein synthesis (Hernández-Ortega et al., 2016).